Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US.

BMJ · 2022 · PMC9597610 · PMID 36288813

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

close to significanceno p-value reported

However, this finding should be put in context with previous research, because some of our estimates were close to significance, suggesting a potential increased risk of venous thromboembolism with thrombocytopenia syndrome after vaccination with Ad26.COV2.S.

also in 2,130 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.